Acute leukemias are life-threatening blood conditions that need urgent treatment. Approved targeted therapies such as BCL2, IDH, and menin inhibitors have expanded treatment options for certain patients, but determining if a given patient might benefit from one of these treatments can take time. Doctors need to order multiple complex diagnostic workups that can take days … Read more
Many cancer therapies work by docking into specific “binding pockets” on the surface of proteins that are driving the disease. Scientists are continually searching for new binding sites for future cancer drugs, but this process can be slow and cumbersome. Now, researchers at Dana-Farber Cancer Institute, in collaboration with scientists at MIT and École Polytechnique … Read more
Kornelia Polyak, MD, PhD, has been trying to understand how breast cancer forms ever since starting her lab at Dana-Farber in 1998. Specifically, she has wanted to know how ductal carcinoma in situ (DCIS), a pre-cancerous state that appears only in the milk ducts in the breast, changes into invasive breast cancer, which is breast … Read more
An exercise-related hormone, irisin, administered to animals with a model of Parkinson’s disease reduced nerve degeneration and symptoms associated with the progressive movement disorder, say scientists from Dana-Farber and Johns Hopkins Medicine. About one million people in the United States, and 10 million people worldwide are living with Parkinson’s, which is characterized by tremors, slowed … Read more